SharkNinja SN 深 滬
已收盤 05-08 16:00:00 美东时间
111.67
-1.450
-1.28%
華盛通- 最 高115.02
- 今 開115.00
- 成交量 178.41万股
- 最 低 110.53
- 昨 收 113.12
- 總市值 158.09亿
- 52周最高 133.99
- 市盈率 靜 22.62
- 換手率 1.26%
- 52周最低 80.69
- 委 比 61.98%
- 總股本 1.42亿
- 歷史最高 133.99
- 量 比 0.76
- 振 幅 3.97%
- 歷史最低 24.76
- 每 手 1
- 風險率 12.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
Top household appliances stocks after Whirlpool’s earnings stumble
Whirlpool (WHR) disappointing Q1 results have reshuffled the household appliances sector, with shares plunging approximately 13% in Thursday midafternoon trading following misses on both revenue and e...
05-08 03:02
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
SharkNinja shares are trading lower. The company reported Q1 financial results.
SharkNinja shares are trading lower. The company reported Q1 financial results.
05-07 00:53
财报速睇 | SharkNinja 2026财年Q1营收14.13亿美元，同比增长15.6%；归母净利润1.21亿美元，同比增长3.1%
华盛资讯5月6日讯，SharkNinja公布2026财年Q1业绩，公司Q1营收14.13亿美元，同比增长15.6%，归母净利润1.21亿美元，同比增长3.1%。
05-06 19:44
财报速睇 | SharkNinja 2026财年Q1营收14.13亿美元，同比增长15.6%；归母净利润1.21亿美元，同比增长3.1%
华盛资讯5月6日讯，SharkNinja公布2026财年Q1业绩，公司Q1营收14.13亿美元，同比增长15.6%，归母净利润1.21亿美元，同比增长3.1%。
05-06 19:31
SharkNinja Q1 Adj. EPS $1.09 Beats $1.03 Estimate, Sales $1.413B Beat $1.382B Estimate
SharkNinja (NYSE:SN) reported quarterly earnings of $1.09 per share which beat the analyst consensus estimate of $1.03 by 5.83 percent. This is a 25.29 percent increase over earnings of $0.87 per share from the same
05-06 19:02
Apple Hunts Backup As Chip Shortage Bites—Intel, Samsung Step In
Apple explores Intel and Samsung as potential chip suppliers to diversify its supply chain and reduce reliance on Taiwan Semiconductor.
05-05 17:29
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
Canaccord Genuity Maintains Buy on SharkNinja, Raises Price Target to $161
Canaccord Genuity analyst Brian McNamara maintains SharkNinja (NYSE:SN) with a Buy and raises the price target from $160 to $161.
05-04 23:26
